Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 6143
TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111607(US8623903, I-16)
Affinity DataIC50: 1.30nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111600(US8623903, I-7)
Affinity DataIC50: 1.80nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111602(US8623903, I-9)
Affinity DataIC50: 2nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111609(US8623903, I-21)
Affinity DataIC50: 3nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111608(US8623903, I-20)
Affinity DataIC50: 3.80nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111599(US8623903, I-6)
Affinity DataIC50: 4.80nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111601(US8623903, I-8)
Affinity DataIC50: 4.90nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111604(US8623903, I-11)
Affinity DataIC50: 4.90nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111603(US8623903, I-10)
Affinity DataIC50: 6.90nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111605(US8623903, I-12)
Affinity DataIC50: 6.90nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111613(US8623903, I-32)
Affinity DataIC50: 7nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111610(US8623903, I-23)
Affinity DataKi:  1.40nM IC50: 1.60nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111612(US8623903, I-31)
Affinity DataKi:  4.30nM IC50: 2.90nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111611(US8623903, I-30)
Affinity DataKi:  5.40nM IC50: 1.20nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111606(US8623903, I-14)
Affinity DataKi:  5.60nM IC50: 2.20nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111597(US8623903, I-1)
Affinity DataKi:  7.70nM IC50: 4.70nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetProstaglandin D2 receptor 2(Human)
Shionogi

US Patent
LigandPNGBDBM111598(US8623903, I-5)
Affinity DataKi:  22nM IC50: 4.10nMAssay Description:A prepared WP was homogenated and a membrane fraction was collected with high-speed centrifugation. A compound of the present invention was added to ...More data for this Ligand-Target Pair
In DepthDetails
US Patent